Recursion Reports Third Quarter 2025 Financial Results and …
Nov 5, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New …
Pioneering AI Drug Discovery | Recursion
All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc.
How a First-of-its-Kind “Microglia Map” from Recursion and Roche …
Oct 29, 2025 · A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a …
Recursion Pharmaceuticals, Inc. - Recursion and Exscientia Enter ...
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal, the San …
Recursion Pharmaceuticals, Inc. - Recursion Announces Webinar …
Dec 1, 2025 · Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry …
Recursion Pharmaceuticals, Inc. - Recursion to Present at 44th …
Jan 6, 2026 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New …
Recursion Pharmaceuticals, Inc. - Preliminary Phase 1b/2 Data for …
May 4, 2025 · Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry …
Models - portfolio.recursion.com
Dive into an interactive experience with our pipeline, partners and models.
Since Its Inception, Recursion has Been Building the Foundation …
Since Recursion was founded in 2013, the company has focused on fundamentally shifting the way drugs are made using data and AI – from an emphasis on generating proprietary data …